{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T22:20:44Z","timestamp":1761862844159},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2009,7,18]],"date-time":"2009-07-18T00:00:00Z","timestamp":1247875200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Internist"],"published-print":{"date-parts":[[2009,8]]},"DOI":"10.1007\/s00108-009-2438-3","type":"journal-article","created":{"date-parts":[[2009,7,16]],"date-time":"2009-07-16T17:28:37Z","timestamp":1247765317000},"page":"979-987","source":"Crossref","is-referenced-by-count":4,"title":["Helicobacter pylori"],"prefix":"10.1007","volume":"50","author":[{"given":"W.","family":"Fischbach","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,7,18]]},"reference":[{"key":"2438_CR1","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1055\/s-0028-1109062","volume":"47","author":"Fischbach","year":"2009","unstructured":"Fischbach W, Malfertheiner P, Hoffmann JC et al. (2009) S3-Leitlinie \u201eHelicobacter pylori und gastroduodenale Ulkuskrankheit\u201c der Deutschen Gesellschaft f\u00fcr Verdauungs- und Stoffwechselkrankheiten (DGVS). In Zusammenarbeit mit der Deutschen Gesellschaft f\u00fcr Hygiene und Mikrobiologie, Gesellschaft f\u00fcr P\u00e4diatrische Gastroenterologie und Ern\u00e4hrung e.V. und der Deutschen Gesellschaft f\u00fcr Rheumatologie \u2013 AWMF-Register-Nr. 021\/001. Z Gastroenterol 47: 68\u2013102","journal-title":"Z Gastroenterol"},{"key":"2438_CR2","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1136\/gut.53.1.34","volume":"53","author":"Fischbach","year":"2004","unstructured":"Fischbach W, Goebeler-Kolve ME, Dragosics B et al. (2004) Long term outcome of patients with gastric marginal zone B cell lymphoma of mucosa associated lymphoid tissue (MALT) following exclusive Helicobacter pylori eradication therapy: experience from a large prospective series. Gut 53: 34\u201337","journal-title":"Gut"},{"key":"2438_CR3","first-page":"CD003840","volume":"Rev","author":"Ford","year":"2006","unstructured":"Ford AC, Delaney BC, Forman D, Moayyedi P (2006) Eradication therapy for peptic ulcer disease in Helicobacter pylori positive patients. Cochrane Database Syst Rev: CD003840","journal-title":"Cochrane Database Syst"},{"key":"2438_CR4","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1365-2036.2006.02737.x","volume":"23","author":"Gisbert","year":"2006","unstructured":"Gisbert JP, Morena F (2006) Systematic review and meta-analysis: levofloxacin-based rescue regimens after Helicobacter pylori treatment failure. Aliment Pharmacol Ther 23: 35\u201344","journal-title":"Aliment Pharmacol Ther"},{"key":"2438_CR5","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1055\/s-2003-42158","volume":"128","author":"Grimm","year":"2003","unstructured":"Grimm W, Fischbach W (2003) Helicobacter pylori infection in children and juveniles: an epidemiological study on prevalence, socio-economic factors and symptoms. Dtsch Med Wochenschr 128: 1878\u20131883","journal-title":"Dtsch Med Wochenschr"},{"key":"2438_CR6","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1046\/j.1365-2036.2001.01109.x","volume":"15","author":"Leodolter","year":"2001","unstructured":"Leodolter A, Kulig M, Brasch H et al. (2001) A meta-analysis comparing eradication, healing and relapse rates in patients with Helicobacter pylori-associated gastric or duodenal ulcer. Aliment Pharmacol Ther 15: 1949\u20131958","journal-title":"Aliment Pharmacol Ther"},{"key":"2438_CR7","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1046\/j.1365-2036.2003.01695.x","volume":"18","author":"Malfertheiner","year":"2003","unstructured":"Malfertheiner P, Layer P, Fischbach W, M\u00f6ssner J (2003) Helicobacter pylori eradication is beneficial in the treatment of functional dyspepsia. Aliment Pharmacol Ther 18: 615\u2013625","journal-title":"Aliment Pharmacol Ther"},{"key":"2438_CR8","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1136\/gut.2006.101634","volume":"56","author":"Malfertheiner","year":"2007","unstructured":"Malfertheiner P, Megraud F, O\u2019Morain C, Bazzoli F et al. (2007) Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report. Gut 56: 772\u2013781","journal-title":"Gut"},{"key":"2438_CR9","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1523-5378.2007.00588.x","volume":"13","author":"Miehlke","year":"2008","unstructured":"Miehlke S, Schneider-Brachert W, Kirsch C et al. (2008) One-week once-daily triple therapy with esomeprazole, moxifloxacin and rifabutin for eradication of persistent Helicobacter pylori resistant to both metronidazole and clarithromycin. Helicobacter 13: 69\u201374","journal-title":"Helicobacter"},{"key":"2438_CR10","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1365-2036.2006.03179.x","volume":"25","author":"Tong","year":"2007","unstructured":"Tong JL, Ran ZH et al. (2007) Meta-analysis: the effect of supplementation with probiotics on eradication rates and adverse events during Helicobacter pylori eradication therapy. Aliment Pharmacol Ther 25: 55\u201368","journal-title":"Aliment Pharmacol Ther"},{"key":"2438_CR11","first-page":"1311","volume":"1","author":"Warren","year":"1984","unstructured":"Warren JR, Marshall BJ (1984) Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 1: 1311\u20131315","journal-title":"Lancet"},{"key":"2438_CR12","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1136\/gut.2007.125658","volume":"56","author":"Zullo","year":"2007","unstructured":"Zullo A, De Francesco V et al. (2007) The sequential therapy regimen for Helicobacter pylori eradication: a pooled-data analysis. Gut 56: 1353\u20131357","journal-title":"Gut"}],"container-title":["Der Internist"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-009-2438-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00108-009-2438-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-009-2438-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,15]],"date-time":"2024-03-15T08:31:37Z","timestamp":1710491497000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00108-009-2438-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7,18]]},"references-count":12,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2009,8]]}},"alternative-id":["2438"],"URL":"https:\/\/doi.org\/10.1007\/s00108-009-2438-3","relation":{},"ISSN":["0020-9554","1432-1289"],"issn-type":[{"value":"0020-9554","type":"print"},{"value":"1432-1289","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,7,18]]}}}